Picture of Cheil Bio Co logo

052670 Cheil Bio Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Annual cashflow statement for Cheil Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARSAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2,043994-712-1,708-1,446
Depreciation
Deferred Taxes
Non-Cash Items-8521,8522,275568-557
Unusual Items
Other Non-Cash Items
Changes in Working Capital3,434-5,507-2,1478,606-2,251
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities5,018-2,297-1047,729-4,072
Capital Expenditures-13.8-13.9-65-11.5-214
Purchase of Fixed Assets
Other Investing Cash Flow Items-6434,628-7,7156,897-1,569
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-6574,614-7,7806,885-1,783
Financing Cash Flow Items-400
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-58.66,382-41.8-3,083-39.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4,3118,491-7,89011,515-5,896